Introduction
challenge. They include principally b2-microglobulin amyloidosis (b2m amyloidosis). In addition, exposure Bacterial contamination of dialysate and the potential to bacteria may also promote two frequent complications transfer of bacterial components from the dialysate in dialysis patients: malnutrition and atherosclerosis. into the blood compartment have been recognized as The influence of bacterial contamination of dialysate on factors predisposing to clinical complications during the pathogenesis of these complications is difficult to chronic treatment by haemodialysis. This problem, demonstrate because many other factors may intervene. however, has been largely neglected. Concerns regard-However, there is evidence that the use of contaminated ing the improvement of dialysate quality have been dialysate is linked with b2m amyloidosis [2] . raised further by two modifications in haemodialysis: (i) the increasing use of high-flux dialysers, which b2m Amyloidosis enhances backfiltration of dialysate and (ii) the introduction of on-line haemodiafiltration, which requires The repeated activation of monocytes by bacterial infusing large quantities of dialysate in the blood contaminants during haemodialysis sessions could be compartment as substitution fluid. a determinant factor of b2m amyloidosis. Dialysate The clinical complications associated with bacterial contaminated with endotoxin stimulates the release of contamination of dialysate are reviewed. The recom-b2m from monocytes. In addition, b2m amyloid fibrils mendations of Pharmacopoeia are also discussed.
can be formed in the supernatant of peripheral blood mononuclear cells maintained in culture [3] . Endotoxin also stimulates monocyte production of interleukin-1
What clinical complications are associated with the (IL-1) and tumour necrosis factor ( TNF ), which are transfer of bacterial products from the dialysate bone resorbing cytokines.
into the patient blood?
The study performed in Marseilles in 1991 gave clinical evidence that bacterial contamination of Short-term complications dialysate may increase the incidence of carpal tunnel syndrome [2] . After 10 years of haemodialysis treatExposure to high levels of bacteria and endotoxin is ment, the proportion of patients with carpal tunnel clearly associated with short-term complications. These syndrome was 38% in patients treated with standard complications range from pyrogenic reactions, includwater, and it was only 5% in patients treated with ing chills and fever, to septicaemia with severe hypoten-'ultrapure' water. Endotoxin concentration in standard sion and shock. Manifestations attributed to endotoxin water was 0.025 ng/ml or 0.125 endotoxin units exposure also include nausea, myalgia, headache, (EU )/ml, and it was 0.008 ng/ml or 0.05 EU/ml in lassitude and sleepiness [1] .
'ultrapure' water. In Hanover, Schwalbe et al. reported that b2m amyloidosis prevalence decreased between Long-term complications 1988 and 1996 [4] . The prevalence of carpal tunnel These complications are considered to result from the syndrome decreased from 16 to 2% and the prevalence stimulation of the organism by long-term endotoxin of radiological signs of b2m amyloidosis decreased from 38 to 8%. Such decrease was attributed to higher Correspondence and offprint requests to: Prof. Y. Berland, Service de dialysate purity, after introduction of reverse osmosis water for dialysate preparation in a larger number of patients in 1996 than in 1988. It is unlikely that Does contamination vary with the type of differences in haemodialysis membranes account for membrane? the results of these two studies. In the first study only cellulosic dialysers were used. In the second the time The transfer of bacterial products from dialysate into spent on high-flux dialysers was low in both the 1988 blood compartment has been described with all types and 1996 time periods.
of haemodialysis membranes. Low-flux membranes do not avoid the risk of contamination because they permit the transfer of bacterial products by backdiffuAtherosclerosis sion [11] . It has been claimed that synthetic membranes reduce the endotoxin transfer from dialysate because An increasing body of evidence suggests that infections they can adsorb these products on their surface. These play a role in the development of atherosclerosis. At synthetic membranes, however, have shown large varipresent chronic low-grade infections like those with ability in their permeability to endotoxins [12] . This Herpesviruses, Chlamydia pneumoniae, or Helicobacter suggests that bacterial contamination of dialysate pylori have been linked with atherosclerosis [5] . The should be avoided with all types of dialysis membranes. mechanisms that could mediate the effect of bacterial infections on atherogenesis mainly involve lipopolysaccharide (LPS ). Thus, it is conceivable that long-Is there a 'safe' level of bacterial contamination of term transfer of LPS from dialysate into the patient's dialysate? blood may also contribute to atherosclerosis. LPS promotes atherosclerosis and vascular thrombosis by The European Pharmacopoeia currently sets the upper its effects on endothelial cell function [5] . LPS increases levels of bacteria and endotoxins in dialysis water at the synthesis of proinflammatory cytokines such as 100 micro-organisms and 0.250 EU/ml [13] . It has IL-1 and TNF in endothelial cells. It induces procoagu-been shown that pyrogenic reactions are induced by lant activity in vascular endothelium by increasing the an endotoxin load of 5 EU/kg [14] . This represents a production of tissue factor, plasminogen activator load of 300 EU for a patient weighing 60 kg. A load inhibitor, and von Willebrand factor antigen. LPS of 300 EU is attained if 1.2 l of dialysate is backfiltered increases the adherence of granulocytes and monocytes with an endotoxin concentration of 0.250 EU/ml. Note to endothelium. LPS also activates monocytes and that much more than 1.2 l is backfiltered during a stimulates production of acute-phase proteins such as dialysis session with a high-flux dialyser. This suggests C-reactive protein, which may also control monocyte/ that the standards of the Pharmacopoeia are not macrophage activation. Plasma levels of C-reactive sufficiently strict for high-flux haemodialysis. protein are highly predictive of cardiovascular risk [6 ] .
It is difficult to determine the endotoxin level that Interestingly, it has been demonstrated that dialysate guarantees that long-term dialysis complications are backfiltration is associated with an increase in avoided. Many long-term complications are linked C-reactive protein in plasma [7] .
with increased cytokine production by monocytes. Nanobacteria, which are calcification-inducing Monocytes produce IL-1 in vitro when incubated with pathogens, may also be involved. Nanobacteria are endotoxin concentrations as low as 50 pg/ml (0.250 micro-organisms that produce carbonate apatite, the EU/ml ) [15] . This again suggests that endotoxin consolid mineral present in most extraskeletal tissue calci-centrations in dialysis water should be kept at levels fication. Nanobacteria could contribute to calcification much lower than the standards of the Pharmacopoeia. of atherosclerosis plaques occurring in haemodialysis Maximal benefit could be obtained with the 'ultrapure' patients [8] . Nanobacteria can pass through 0.1-mm dialysate; it contains an endotoxin concentration filters and possess unusual properties making their inferior to 0.05 EU/ml and less than 0.1 microdetection difficult with standard microbiological organisms/ml [2] . methods. They have been detected in human blood
The recent development of haemodiafiltration using and urine, however, it is not known whether they can dialysate as substitution fluid needs special consideradevelop in dialysate.
tion. This technique is achieved by the infusion of large amounts of dialysate, ranging from 15-30 l per session. Taking into account the maximal endoMalnutrition toxin load of 5 EU/kg, it is imperative to use sterile dialysate. The definition of sterility used in the pharmaBacterial contamination of dialysate may also cause malnutrition in haemodialysis patients through direct ceutical industry cannot be applied to an on-line prepared fluid. However, the maximal quality standards effects of LPS, which impairs protein catabolism in skeletal muscle [9] and induces anorexia by stimulating should be achieved for infused dialysate. Microorganisms should be undetectable and endotoxin conthe production of leptin [10] . LPS may also indirectly affect the development of malnutrition by inducing centrations should be inferior to 0.01 EU/ml, the detection limit of the most sensitive Limulus amoeproinflammatory cytokine production by monocytes. These cytokines induce anorexia, enhanced muscle bocyte lysate assays. In addition, the benefit of enhancing clearances of high molecular weight uraemic toxins catabolism, and reduced muscle protein synthesis, and protein utilisation.
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